NPI: 1952954307 · ALLENTOWN, PA 18103 · Children's Hospital · NPI assigned 07/24/2019
Authorized official THOMAS, ROBERT controls 20+ related entities in our dataset. Read more
| Authorized Official | THOMAS, ROBERT (REGIONAL CFO) |
| NPI Enumeration Date | 07/24/2019 |
Other providers sharing the same authorized official: THOMAS, ROBERT
| Year | Claims | Total Paid |
|---|---|---|
| 2020 | 3,160 | $389K |
| 2021 | 15,344 | $2.88M |
| 2022 | 11,163 | $1.96M |
| 2023 | 19,500 | $2.61M |
| 2024 | 19,792 | $2.16M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 13,836 | 13,672 | $3.81M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 17,610 | 17,278 | $3.28M |
| G0378 | Hospital observation service, per hour | 705 | 659 | $1.73M |
| T1015 | Clinic visit/encounter, all-inclusive | 5,452 | 1,666 | $294K |
| D2930 | Prefabricated stainless steel crown - primary tooth | 160 | 159 | $225K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 159 | 158 | $145K |
| 54161 | 341 | 341 | $125K | |
| 14040 | 64 | 64 | $88K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 110 | 110 | $51K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 527 | 526 | $37K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 125 | 123 | $31K |
| D1120 | Prophylaxis - child | 108 | 108 | $27K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 175 | 145 | $24K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 80 | 76 | $24K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3,511 | 2,944 | $19K |
| 54360 | 12 | 12 | $14K | |
| 54300 | 43 | 43 | $11K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 105 | 105 | $11K |
| 80053 | Comprehensive metabolic panel | 1,109 | 992 | $10K |
| 92523 | 67 | 67 | $6K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 169 | 146 | $5K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 14 | 14 | $5K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 16 | 16 | $4K |
| 82728 | 339 | 316 | $4K | |
| 87631 | 13 | 13 | $3K | |
| 85045 | 471 | 418 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 72 | 56 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 63 | 61 | $2K |
| 96409 | 20 | 12 | $940.44 | |
| 82947 | 281 | 272 | $885.30 | |
| 81003 | 294 | 278 | $662.08 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 32 | 28 | $604.84 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 15 | 14 | $600.97 |
| 85027 | 71 | 70 | $560.92 | |
| 85652 | 165 | 156 | $372.55 | |
| 86140 | 168 | 158 | $359.76 | |
| 84466 | 13 | 13 | $211.34 | |
| 71046 | Radiologic examination, chest; 2 views | 15 | 15 | $167.72 |
| J7050 | Infusion, normal saline solution, 250 cc | 1,292 | 955 | $163.60 |
| G0008 | Administration of influenza virus vaccine | 17 | 16 | $131.61 |
| 83540 | 13 | 13 | $105.10 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 1,767 | 1,550 | $98.85 |
| 81001 | 29 | 27 | $75.86 | |
| 36415 | Collection of venous blood by venipuncture | 97 | 86 | $71.23 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 2,993 | 2,606 | $52.44 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,560 | 2,343 | $38.52 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 2,333 | 2,230 | $32.31 |
| 90688 | 32 | 32 | $27.09 | |
| J2704 | Injection, propofol, 10 mg | 2,044 | 1,798 | $15.40 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 2,277 | 2,242 | $1.41 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1,282 | 1,214 | $1.23 |
| A9270 | Non-covered item or service | 2,033 | 1,105 | $0.00 |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | 64 | 55 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 515 | 473 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 40 | 36 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 60 | 49 | $0.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 62 | 58 | $0.00 |
| D1206 | Topical application of fluoride varnish | 65 | 65 | $0.00 |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | 13 | 13 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 64 | 41 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 778 | 766 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 868 | 851 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 447 | 425 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 274 | 256 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 32 | 28 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 45 | 41 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 311 | 308 | $0.00 |
| J1756 | Injection, iron sucrose, 1 mg | 22 | 14 | $0.00 |